TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Dig Itself out of its Financial Hole?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in danger of defaulting on its debt.

    Read more »

    The Motley Fool
    Investing

    Sell and Avoid Valeant Pharmaceuticals Intl Inc.

    Because of negative situations, investors should flee Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and avoid it for good.

    Read more »

    The Motley Fool
    Investing

    Why Bill Ackman Makes Valeant Pharmaceuticals Intl Inc. Shareholders Nervous

    Pershing Square may have to sell shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), driving the shares down further.

    Read more »

    The Motley Fool
    Investing

    Why My Price Target for Valeant Pharmaceuticals Intl Inc. Is $0

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) should not be bought at any price.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 Things to Look for as it Reports 4th-Quarter Numbers

    After two delays, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will finally report fourth-quarter results on Tuesday.

    Read more »

    The Motley Fool
    Investing

    Why Are Valeant Pharmaceuticals Intl Inc. Shares Surging?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares are flying high. What is going on?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Why the SEC Investigation Is a Very Big Deal

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a serious problem on its hands.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A Timeline of the Monday Nightmare

    Why did Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) fall more than 18% on Monday?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is Under Scrutiny From the SEC

    The list of problems grows for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 More Game-Changing Updates

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) likes to keep investors guessing.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is it a Turnaround Candidate or Is More Trouble Ahead?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is both loved and loathed by investors, and recent events might be the start of…

    Read more »

    The Motley Fool
    Investing

    Was Andrew Left Right About Valeant Pharmaceuticals Intl Inc.?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have some explaining to do.

    Read more »